Blog
FDA will release draft guidance on accepting clinical data performed outside the United States for medical devices
Set to release Tuesday, April 28, FDA plans to issue a draft guidance document regarding its current policy of accepting clinical trial data performed outside the United States in support of medical device premarket submissions. To be clear, this document is not...
Diana Caldwell, President and CEO of Pearl Pathways, named Indiana’s Outstanding Achiever on behalf of CEED
Pearl Pathways is excited to announce that its President and CEO, Diana Caldwell, has been honored as the Center for Empowerment & Economic Development’s (CEED) Indiana Outstanding Achiever this year. This award is granted by CEED to individuals or organizations...
Projected CRO Growth in Latin America Due to Lower-Cost Market
A recent study by Frost & Sullivan shows that the clinical research market for contract research organizations (CROs) in Latin America are projected to grow at a rate of 7.1% for the next four years, as it predicts that the larger CROs will take the greatest...
Indiana Life Sciences Collaboration Conference Series Upcoming Event on May 8
As a sponsor of the 2014-2015 Indiana Life Sciences Collaboration Conference Series, Pearl Pathways would like to announce the upcoming conference entitled The Changing Role of the Consumer in Healthcare. We invite you to join us at the event on Friday, May 8, where a...
Pearl Pathways sponsoring, attending 6th Semi-Annual IVD Conference in San Diego
Pearl Pathways is excited to sponsor Q1 Productions’ and attend its upcoming IVD conference on Clinical Affairs and Regulatory Approvals for Diagnostics. The conference provides an excellent opportunity to network with industry experts and gain additional insight on...